Drug-bearing supramolecular filament hydrogels as anti-inflammatory agents

Theranostics

Volumn 7, Issue 7, 2017, Pages 2003-2014

  Chen, Zhipeng ^a,c   Xing, Lei ^b   Fan, Qin ^a   Cheetham, Andrew G ^c   Lin, Ran ^c   Holt, Barbara ^c   Chen, Liwen ^c   Xiao, Yanyu ^b   Cui, Honggang ^c,d,e  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c Johns Hopkins University   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Drug delivery; Peptide drug conjugate; Rheumatoid arthritis; Self assembly; Supramolecular hydrogel

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INTERLEUKIN 1; KETOPROFEN; PRODRUG; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; DRUG CARRIER;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CHONDROCYTE; CONTROLLED STUDY; DRUG POTENCY; DRUG PURIFICATION; DRUG SELECTIVITY; DRUG STRUCTURE; ENANTIOMER; HYDROGEL; MALE; NONHUMAN; RAT; RHEUMATOID ARTHRITIS; SLOW DRUG RELEASE; SYNOVIOCYTE; ADMINISTRATION AND DOSAGE; ANIMAL; CELL CULTURE; DRUG EFFECTS; FIBROBLAST; INTRAARTICULAR DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; DRUG CARRIERS; FIBROBLASTS; HYDROGELS; INJECTIONS, INTRA-ARTICULAR; KETOPROFEN; RATS;

EID: 85019891859     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.19404     Document Type: Article

References (87)

1. Dubikovskaya EA, Thorne SH, Pillow TH, Contag CH, Wender PA. Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105:12128-33.
2. Cheetham AG, Zhang P, Lin Y-A, Lock LL, Cui H. Supramolecular nanostructures formed by anticancer drug assembly. Journal of the American Chemical Society. 2013; 135:2907-10.
3. Ma W, Cheetham AG, Cui HG. Building nanostructures with drugs. Nano Today. 2016; 11:13-30.
4. Su H, Koo JM, Cui HG. One-component nanomedicine. Journal of Controlled Release. 2015; 219:383-95.
5. Geng LL, Wang ZH, Jia XQ, Han QJ, Xiang ZC, Li D, et al. HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery. Theranostics. 2016; 6:1261-73.
6. Park SH, Zheng JH, Nguyen VH, Jiang SN, Kim DY, Szardenings M, et al. RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy. Theranostics. 2016; 6:1672-82.
7. Wang Y, Cheetham AG, Angacian G, Su H, Xie L, Cui H. Peptide-drug conjugates as effective prodrug strategies for targeted delivery. Advanced Drug Delivery Reviews. 2016. http://dx.doi.org/10.1016/j.addr.2016.06.015
8. Chen Z, Zhang P, Cheetham AG, Moon JH, Moxley JW, Lin Y-a, et al. Controlled release of free doxorubicin from peptide-drug conjugates by drug loading. Journal of Controlled Release. 2014; 191:123-30.
9. Shu JY, Panganiban B, Xu T. Peptide-polymer conjugates: from fundamental science to application. Annual review of physical chemistry. 2013; 64:631-57.
10. Fleming S, Ulijn RV. Design of nanostructures based on aromatic peptide amphiphiles. Chem Soc Rev. 2014; 43:8150-77.
11. Hamley IW. Lipopeptides: from self-assembly to bioactivity. Chem Commun. 2015; 51:8574-83.
12. Du X, Zhou J, Guvench O, Sangiorgi FO, Li X, Zhou N, et al. Supramolecular assemblies of a conjugate of nucleobase, amino acids, and saccharide act as agonists for proliferation of embryonic stem cells and development of zygotes. Bioconjugate chemistry. 2014; 25:1031-5.
13. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science. 2001; 294:1684-8.
14. Stupp SI, Zha RH, Palmer LC, Cui HG, Bitton R. Self-assembly of biomolecular soft matter. Faraday Discussions. 2013; 166:9-30.
15. Mlinar LB, Chung EJ, Wonder EA, Tirrell M. Active targeting of early and mid-stage atherosclerotic plaques using self-assembled peptide amphiphile micelles. Biomaterials. 2014; 35:8678-86.
16. Trent A, Marullo R, Lin B, Black M, Tirrell M. Structural properties of soluble peptide amphiphile micelles. Soft Matter. 2011; 7:9572-82.
17. Li Y, Wang F, Cui H. Peptide-Based Supramolecular Hydrogels for Delivery of Biologics. Bioengineering & Translational Medicine. 2016; 1: 306-322.
18. Wolinsky JB, Colson YL, Grinstaff MW. Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers. Journal of Controlled Release. 2012; 159:14-26.
19. Xi HL, Cun DM, Xiang RW, Guan YL, Zhang YX, Li YR, et al. Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: Does the topical patch really enhance a local treatment? Journal of Controlled Release. 2013; 169:73-81.
20. Lin R, Cui H. Supramolecular nanostructures as drug carriers. Current Opinion in Chemical Engineering. 2015; 7:75-83.
21. Sun JEP, Stewart B, Litan A, Lee SJ, Schneider JP, Langhans SA, et al. Sustained release of active chemotherapeutics from injectable-solid beta-hairpin peptide hydrogel. Biomaterials Science. 2016; 4:839-48.
22. Tatman PD, Muhonen EG, Wickers ST, Gee AO, Kim ES, Kim DH. Self-assembling peptides for stem cell and tissue engineering. Biomaterials Science. 2016; 4:543-54.
23. Thakkar H, Sharma RK, Mishra A, Chuttani K, Murthy R. Efficacy of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints. Journal of Pharmacy and Pharmacology. 2004; 56:1091-9.
24. Bakker AC, ARNTZ J. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-l receptor antagonist protein in the knee. Arthritis Rheum. 1997; 40:893-900.
25. Larsen C, Østergaard J, Larsen SW, Jensen H, Jacobsen S, Lindegaard C, et al. Intra-articular depot formulation principles: Role in the management of postoperative pain and arthritic disorders. Journal of Pharmaceutical Sciences. 2008; 97:4622-54.
26. Burt HM, Tsallas A, Gilchrist S, Liang LS. Intra-articular drug delivery systems: overcoming the shortcomings of joint disease therapy. Expert Opin Drug Deliv. 2009; 6:17-26.
27. Betre H, Liu W, Zalutsky MR, Chilkoti A, Kraus VB, Setton LA. A thermally responsive biopolymer for intra-articular drug delivery. Journal of Controlled Release. 2006; 115:175-82.
28. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis -The CLASS study: A randomized controlled trial. Jama-Journal of the American Medical Association. 2000; 284:1247-55.
29. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology. 1997; 112:1000-16.
30. Zhao F, Ma ML, Xu B. Molecular hydrogels of therapeutic agents. Chem Soc Rev. 2009; 38:883-91.
31. Chen CY, Ke CJ, Yen KC, Hsieh HC, Sun JS, Lin FH. 3D Porous Calcium-Alginate Scaffolds Cell Culture System Improved Human Osteoblast Cell Clusters for Cell Therapy. Theranostics. 2015; 5:643-55.
32. Tondera C, Hauser S, Kruger-Genge A, Jung F, Neffe AT, Lendlein A, et al. Gelatin-based Hydrogel Degradation and Tissue Interaction in vivo: Insights from Multimodal Preclinical Imaging in Immunocompetent Nude Mice. Theranostics. 2016; 6:2114-28.
33. Zelzer M, Todd SJ, Hirst AR, McDonald TO, Ulijn RV. Enzyme responsive materials: design strategies and future developments. Biomaterials Science. 2013; 1:11-39.
34. Du X, Zhou J, Shi J, Xu B. Supramolecular hydrogelators and hydrogels: from soft matter to molecular biomaterials. Chem Rev. 2015; 115:13165-307.
35. Giano MC, Pochan DJ, Schneider JP. Controlled biodegradation of Self-assembling beta-hairpin Peptide hydrogels by proteolysis with matrix metalloproteinase-13. Biomaterials. 2011; 32:6471-7.
36. Boekhoven J, Stupp SI. 25th anniversary article: supramolecular materials for regenerative medicine. Advanced materials. 2014; 26:1642-59.
37. Tansik G, Kilic E, Beter M, Demiralp B, Sendur GK, Can N, et al. A glycosaminoglycan mimetic peptide nanofiber gel as an osteoinductive scaffold. Biomaterials Science. 2016; 4:1328-39.
38. Yu ZQ, Cai Z, Chen QL, Liu MH, Ye L, Ren JY, et al. Engineering beta-sheet peptide assemblies for biomedical applications. Biomaterials Science. 2016; 4:365-74.
39. Hoffman AS. Hydrogels for biomedical applications. Advanced Drug Delivery Reviews. 2012; 64:18-23.
40. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chemical Reviews. 2001; 101:1869-80.
41. Peppas NA, Hilt JZ, Khademhosseini A, Langer R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Advanced materials. 2006; 18:1345-60.
42. Petka WA, Harden JL, McGrath KP, Wirtz D, Tirrell DA. Reversible hydrogels from self-assembling artificial proteins. Science. 1998; 281:389-92.
43. Dong L-C, Hoffman AS. A novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery. Journal of Controlled Release. 1991; 15:141-52.
44. Haraguchi K, Takehisa T. Nanocomposite hydrogels: a unique organic-inorganic network structure with extraordinary mechanical, optical, and swelling/de-swelling properties. Advanced materials. 2002; 14:1120-4.
45. Draper ER, Adams DJ. Chapter 12 Responsive Materials by the Self-assembly of Low Molecular Weight Gelators. Chemoresponsive Materials: Stimulation by Chemical and Biological Signals: The Royal Society of Chemistry; 2015: 332-63.
46. Hu Y, Lin R, Patel K, Cheetham AG, Kan CY, Cui HG. Spatiotemporal control of the creation and immolation of peptide assemblies. Coordination Chemistry Reviews. 2016; 320:2-17.
47. Frederix P, Scott GG, Abul-Haija YM, Kalafatovic D, Pappas CG, Javid N, et al. Exploring the sequence space for (tri-) peptide self-assembly to design and discover. Nature Chemistry. 2015; 7:30-7.
48. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Advanced Drug Delivery Reviews. 2012; 64:49-60.
49. Yoshida R, Uchida K, Kaneko Y, Sakai K, Kikuchi A, Sakurai Y, et al. Comb-type grafted hydrogels with rapid deswelling response to temperature changes. Nature. 1995; 374:240-2.
50. Rodríguez-Llansola F, Hermida-Merino D, Nieto-Ortega B, Ramírez FJ, Navarrete JTL, Casado J, et al. Self-Assembly Studies of a Chiral Bisurea-Based Superhydrogelator. Chem Eur J. 2012; 18:14725-31.
51. Matson JB, Newcomb CJ, Bitton R, Stupp SI. Nanostructure-templated control of drug release from peptide amphiphile nanofiber gels. Soft Matter. 2012; 8:3586-95.
52. Matson JB, Stupp SI. Drug release from hydrazone-containing peptide amphiphiles. Chem Commun. 2011; 47:7962-4.
53. Schmaljohann D. Thermo-and pH-responsive polymers in drug delivery. Advanced Drug Delivery Reviews. 2006; 58:1655-70.
54. Kloxin AM, Kasko AM, Salinas CN, Anseth KS. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science. 2009; 324:59-63.
55. Foo CTWP, Lee JS, Mulyasasmita W, Parisi-Amon A, Heilshorn SC. Two-component protein-engineered physical hydrogels for cell encapsulation. Proceedings of the National Academy of Sciences. 2009; 106:22067-72.
56. Kalafatovic D, Nobis M, Son JY, Anderson KI, Ulijn RV. MMP-9 triggered self-assembly of doxorubicin nanofiber depots halts tumor growth. Biomaterials. 2016; 98:192-202.
57. Gao Y, Yang Z, Kuang Y, Ma M-L, Li J, Zhao F, et al. Enzyme-instructed self-assembly of peptide derivatives to form nanofibers and hydrogels. Pept Sci. 2010; 94:19-31.
58. Yang Z, Gu H, Fu D, Gao P, Lam JK, Xu B. Enzymatic formation of supramolecular hydrogels. Adv Mater. 2004; 16:1440-4.
59. Zhou J, Du X, Yamagata N, Xu B. Enzyme-instructed self-assembly of small D-peptides as a multiple-step process for selectively killing cancer cells. J Am Chem Soc. 2016; 138:3813-23.
60. Serizawa T, Nanameki K, Yamamoto K, Akashi M. Thermoresponsive ultrathin hydrogels prepared by sequential chemical reactions. Macromolecules. 2002; 35:2184-9.
61. Hennink W, Van Nostrum CF. Novel crosslinking methods to design hydrogels. Advanced Drug Delivery Reviews. 2012; 64:223-36.
62. Sargeant TD, Aparicio C, Goldberger JE, Cui H, Stupp SI. Mineralization of peptide amphiphile nanofibers and its effect on the differentiation of human mesenchymal stem cells. Acta biomaterialia. 2012; 8:2456-65.
63. Cheetham AG, Ou YC, Zhang PC, Cui HG. Linker-determined drug release mechanism of free camptothecin from self-assembling drug amphiphiles. Chemical Communications. 2014; 50:6039-42.
64. Su H, Zhang P, Cheetham AG, Koo JM, Lin R, Masood A, et al. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells. Theranostics. 2016; 6:1065-74.
65. MacKay JA, Chen M, McDaniel JR, Liu W, Simnick AJ, Chilkoti A. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nature Materials. 2009; 8:993-9.
66. Keyes-Baig C, Duhamel J, Fung S-Y, Bezaire J, Chen P. Self-assembling peptide as a potential carrier of hydrophobic compounds. Journal of the American Chemical Society. 2004; 126:7522-32.
67. Zhang P, Cheetham AG, Lin Y-A, Cui H. Self-assembled Tat nanofibers as effective drug carrier and transporter. Acs Nano. 2013; 7:5965-77.
68. Carter JM, Qian Y, Foster JC, Matson JB. Peptide-based hydrogen sulphide-releasing gels. Chemical Communications. 2015; 51:13131-4.
69. Lin R, Cheetham AG, Zhang P, Lin Y-a, Cui H. Supramolecular filaments containing a fixed 41% paclitaxel loading. Chemical Communications. 2013; 49:4968-70.
70. Lin Y-A, Cheetham AG, Zhang P, Ou Y-C, Li Y, Liu G, et al. Multiwalled nanotubes formed by catanionic mixtures of drug amphiphiles. ACS nano. 2014; 8:12690-700.
71. Ma W, Su H, Cheetham AG, Zhang W, Wang Y, Kan Q, et al. Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy. Journal of Controlled Release. 2017. http://dx.doi.org/10.1016/j.jconrel.2017.01.015
72. Ottinger EA, Shekels LL, Bernlohr DA, Barany G. Synthesis of phosphotyrosine-containing peptides and their use as substrates for protein tyrosine phosphatases. Biochemistry. 1993; 32:4354-61.
73. Moyer TJ, Cui HG, Stupp SI. Tuning Nanostructure Dimensions with Supramolecular Twisting. Journal of Physical Chemistry B. 2013; 117:4604-10.
74. Cui HG, Cheetham AG, Pashuck ET, Stupp SI. Amino Acid Sequence in Constitutionally Isomeric Tetrapeptide Amphiphiles Dictates Architecture of One-Dimensional Nanostructures. Journal of the American Chemical Society. 2014; 136:12461-8.
75. Cui H, Muraoka T, Cheetham AG, Stupp SI. Self-assembly of giant peptide nanobelts. Nano Letters. 2009; 9:945-51.
76. Hu Y, Lin R, Zhang P, Fern J, Cheetham AG, Patel K, et al. Electrostatic-Driven Lamination and Untwisting of ß-Sheet Assemblies. Acs Nano. 2016; 10:880-8.
77. Shi J, Du X, Yuan D, Zhou J, Zhou N, Huang Y, et al. D-amino acids modulate the cellular response of enzymatic-instructed supramolecular nanofibers of small peptides. Biomacromolecules. 2014; 15:3559-68.
78. Li JY, Kuang Y, Gao Y, Du XW, Shi JF, Xu B. D-Amino Acids Boost the Selectivity and Confer Supramolecular Hydrogels of a Nonsteroidal Anti-Inflammatory Drug (NSAID). Journal of the American Chemical Society. 2013; 135:542-5.
79. Li JY, Kuang Y, Shi JF, Gao YA, Zhou J, Xu B. The conjugation of nonsteroidal anti-inflammatory drugs (NSAID) to small peptides for generating multifunctional supramolecular nanofibers/hydrogels. Beilstein Journal of Organic Chemistry. 2013; 9:908-17.
80. Li XM, Li JY, Gao YA, Kuang Y, Shi JF, Xu B. Molecular Nanofibers of Olsalazine Form Supramolecular Hydrogels for Reductive Release of an Anti-inflammatory Agent. Journal of the American Chemical Society. 2010; 132:17707-9.
81. Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clinical Immunology. 2005; 115:118-28.
82. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Reviews. 2010; 233:233-55.
83. Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nature Reviews Rheumatology. 2013; 9:24-33.
84. Dayer J-M, Demczuk S. Cytokines and other mediators in rheumatoid arthritis. Springer Seminars in Immunopathology; 1984.
85. Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. The American journal of pathology. 1996; 149:1607.
86. Arend WP, Dayer JM. Inhibition of the production and effects of interleukins-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis & Rheumatism. 1995; 38:151-60.
87. Cui HG, Pashuck ET, Velichko YS, Weigand SJ, Cheetham AG, Newcomb CJ, et al. Spontaneous and X-ray-Triggered Crystallization at Long Range in Self-Assembling Filament Networks. Science. 2010; 327:555-9.